Pacific Biosciences of California, Inc. (PACB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 560.92M |
| Enterprise Value | 1.26B |
| P/E Ratio | -5.42 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 4.54 |
| Price/Book Ratio | -21.79 |
| Enterprise/Revenue | 8.59 |
| Enterprise/EBITDA | -12.55 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.82 |
| Operating Margin | -1.02 |
AD
Management Effectiveness
| Return On Assets | -0.17 |
| Return On Equity | -49.62 |
Income Statement
| Revenue | 160.01M |
| Revenue/Share | 0.51 |
| Gross Profit | 50.67M |
| EBITDA | -152.69M |
| Net Income | -546.38M |
| Diluted EPS | -1.82 |
Balance Sheet
| Total Cash | 236.87M |
| Total Cash/Share | 0.76 |
| Total Debt | 706.13M |
| Total Debt/Equity | -21.26 |
| Current Ratio | 4.92 |
| Book Value Per Share | -0.11 |
Price History
| 52-Week Change | 43.83 |
| 52-Week High | 3.44 |
| 52-Week Low | 1.07 |
| Moving Average 50 Days | 1.54 |
| Moving Average 200 Days | 1.59 |
Statistics
| Average Volume | 10.48M |
| Shares Outstanding | 310.6M |
| % Held by Institutions | 62.37 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
